- Home
- MAA vs RLAY Comparison
MAA vs RLAY Comparison
Compare MAA & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAA
- RLAY
- Stock Information
- Founded
- MAA 1977
- RLAY 2015
- Country
- MAA United States
- RLAY United States
- Employees
- MAA N/A
- RLAY N/A
- Industry
- MAA Real Estate Investment Trusts
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MAA Real Estate
- RLAY Health Care
- Exchange
- MAA Nasdaq
- RLAY Nasdaq
- Market Cap
- MAA 16.6B
- RLAY 619.0M
- IPO Year
- MAA 1994
- RLAY 2020
- Fundamental
- Price
- MAA $139.50
- RLAY $4.09
- Analyst Decision
- MAA Buy
- RLAY Strong Buy
- Analyst Count
- MAA 18
- RLAY 13
- Target Price
- MAA $162.50
- RLAY $18.00
- AVG Volume (30 Days)
- MAA 702.6K
- RLAY 1.2M
- Earning Date
- MAA 10-29-2025
- RLAY 11-05-2025
- Dividend Yield
- MAA 4.34%
- RLAY N/A
- EPS Growth
- MAA 10.39
- RLAY N/A
- EPS
- MAA 4.85
- RLAY N/A
- Revenue
- MAA $2,200,155,000.00
- RLAY $8,355,000.00
- Revenue This Year
- MAA $1.96
- RLAY $31.55
- Revenue Next Year
- MAA $3.13
- RLAY N/A
- P/E Ratio
- MAA $28.79
- RLAY N/A
- Revenue Growth
- MAA 1.19
- RLAY N/A
- 52 Week Low
- MAA $137.32
- RLAY $1.78
- 52 Week High
- MAA $173.38
- RLAY $8.19
- Technical
- Relative Strength Index (RSI)
- MAA 40.94
- RLAY 60.92
- Support Level
- MAA $139.01
- RLAY $3.89
- Resistance Level
- MAA $145.80
- RLAY $4.34
- Average True Range (ATR)
- MAA 2.44
- RLAY 0.24
- MACD
- MAA -0.34
- RLAY 0.02
- Stochastic Oscillator
- MAA 6.62
- RLAY 69.94
About MAA Mid-America Apartment Communities Inc.
Mid-America Apartment Communities Inc or MAA, is a real estate investment trust engaged in the acquisition, operation, and development of multifamily apartment communities located in the southeastern and southwestern United States. The company operates two reportable segments; Same Store includes communities that the Company has owned and have been stabilized for at least a full 12 months as of the first day of the calendar year and Non-Same Store and Other includes recently acquired communities, communities being developed or in lease-up, communities that have been disposed of or identified for disposition, communities that have experienced a casualty loss and stabilized communities that do not meet the requirements to be Same Store communities.
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).